According to VBI Vaccines 's latest financial reports the company's total assets are $86.95 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.15 B | -26.25% |
2021-12-31 | $0.21 B | 0.43% |
2020-12-31 | $0.20 B | 71.33% |
2019-12-31 | $0.12 B | -11.19% |
2018-12-31 | $0.13 B | -5.53% |
2017-12-31 | $0.14 B | 39.05% |
2016-12-31 | $0.10 B | 514.57% |
2015-12-31 | $17.04 M | |
2015-03-31 | $81.22 M | -48.32% |
2014-03-31 | $0.15 B | -10.5% |
2013-03-31 | $0.17 B | -5.22% |
2012-03-31 | $0.18 B | -10.79% |
2011-03-31 | $0.20 B | 3957.39% |
2010-03-31 | $5.11 M | 263.13% |
2009-03-31 | $1.4 M | -14.76% |
2008-03-31 | $1.65 M | 9.16% |
2007-03-31 | $1.51 M | 15.73% |
2006-03-31 | $1.3 M | 100.74% |
2005-03-31 | $0.65 M | 117.53% |
2004-03-31 | $0.29 M | 139.04% |
2003-03-31 | $0.12 M | 134.99% |
2002-03-31 | $0.05 M | -90.03% |
2001-03-31 | $0.53 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Onconova Therapeutics ONTX | $22.68 M | -73.91% | ๐บ๐ธ USA |
Curis CRIS | $77.28 M | -11.12% | ๐บ๐ธ USA |
Myriad Genetics MYGN | $1.14 B | 1,218.56% | ๐บ๐ธ USA |